Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
The Trade Debate: Election Outcomes Affected, Public Views Increasingly Negative, Imminent Lame-Duck Fight Over TPP Is First Salvo in Election 2018 November 7, 2016
Rep. Henry Waxman and Colleagues Write to Kirk on Access to Medicines in TPP Negotiations October 19, 2011